Skip to content
Screener

Kiniksa Pharmaceuticals International, plc KNSA Business Segments — PP&E (Net)

Similar metrics at other companies

Costco Wholesale logo
COSTCanada — PP&E (Net)
$3.26B—
Accenture logo
ACNAmericas — PP&E (Net)
$561.32M-8.7%
Accenture logo
ACNEMEA — PP&E (Net)
$510.83M-1.7%
AeroVironment logo
AVAVUxs — PP&E (Net)
$5.03M+72.8%
Consolidated Water Company logo
CWCOBulk — PP&E (Net)
$18.54M+3.6%
Consolidated Water Company logo
CWCOCorporate — PP&E (Net)
$201.83K+5.4%

Other financials

Income statement

See full
Revenue$243.6M+55.4%
Gross profit$220.0M+59.2%
Operating income$27.2M+34.9%
Net income$25.4M+42.6%
EPS (diluted)$0.30+30.4%

Balance sheet

See full
Cash & equivalents$175.7M-8.5%
Total debt$8.9M-8.9%
Total equity$654.1M+32.1%
Total assets$896.1M+35.5%

Cash flow

See full
Operating cash flow$47.2M+68.0%
CapEx$663.0K+302%
Free cash flow$46.5M+66.6%

Valuation

See full
Market cap$5.97B+146%
Enterprise value$5.8B+159%
P/E74×-432×
P/S7.1×+2.5×

Profitability

See full
Gross margin89.8%+3.9pp
Operating margin11.9%+11.1pp
Net margin9.6%+8.7pp
FCF margin21.7%+8.8pp

Returns & leverage

See full
Return on equity14%+13.0pp
Debt / equity0×0.0×
Current ratio3.9×+0.3×

Where this comes from

Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The source filing: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 4:17 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-087545
Line itemJune 30, 2026December 31, 2025
Property and equipment, net
United States$1,414$1,608
United Kingdom11076
Rest of world1,051259
Total property and equipment, net$2,575$1,943

Item 1. Financial Statements (unaudited)

FAQ

What is Kiniksa Pharmaceuticals International, plc's business segments — PP&E (net)?
Kiniksa Pharmaceuticals International, plc (KNSA) reported business segments — PP&E (net) of $2.58M in Q2 2026.
What does business segments — PP&E (net) mean?
The net book value of tangible assets used in the pharmaceutical segment, including laboratory facilities, manufacturing equipment, and office infrastructure. This metric tracks the capital intensity of the business and the scale of physical assets required to support clinical and commercial operations.

Ask your AI about Kiniksa Pharmaceuticals International, plc's business segments — pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude